BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/29/2024 10:30:35 AM | Browse: 272 | Download: 943
 |
Received |
|
2024-03-18 05:48 |
|
Peer-Review Started |
|
2024-03-18 05:48 |
|
First Decision by Editorial Office Director |
|
2024-05-01 07:28 |
|
Return for Revision |
|
2024-05-02 12:53 |
|
Revised |
|
2024-05-03 04:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-05-22 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-05-22 10:44 |
|
Articles in Press |
|
2024-05-22 10:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-31 08:48 |
|
Publish the Manuscript Online |
|
2024-06-29 10:30 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical and Translational Research |
| Article Title |
Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Gwang Ha Kim and Hang Lak Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gwang Ha Kim, MD, PhD, Professor, Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, South Korea. doc0224@pusan.ac.kr |
| Key Words |
Gastritis; Erosive gastritis; Fexuprazan; Rebamipide; Matching-adjusted indirect comparison; Indirect treatment comparison |
| Core Tip |
In a matching-adjusted indirect comparison, the effectiveness of fexuprazan, a novel potassium-competitive acid blocker, was compared with that of rebamipide, one of the most commonly used mucoprotective agents for acute and chronic gastritis in a real-world setting in South Korea. We conclude that a two-week fexuprazan treatment is superior to a two-week rebamipide treatment and similar to a four-week rebamipide treatment for patients with gastritis. |
| Publish Date |
2024-06-29 10:30 |
| Citation |
Kim GH, Lee HL. Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison. World J Clin Cases 2024; 12(19): 3890-3897 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i19/3890.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i19.3890 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
